BiotechTubeBiotechTube
Home/GSK plc/Regis Simard
RS

Regis Simard

President, Pharmaceuticals R&D

GSK plc

Therapeutic Areas

RespiratoryHIVOncologyVaccinesImmunologyInfectious Diseases

GSK plc Pipeline

DrugIndicationPhase
Blenrep (belantamab mafodotin)Multiple MyelomaApproved
Jemperli (dostarlimab)Endometrial CancerApproved
Nucala (mepolizumab)Severe AsthmaApproved
Trelegy ElliptaCOPD, AsthmaApproved
ShingrixHerpes ZosterApproved
ArexvyRSVApproved
GSK3844766HIVPhase 1
GSK3640254Pulmonary Arterial HypertensionPhase 2

Leadership Team at GSK plc

EW
Emma Walmsley
Chief Executive Officer
IM
Iain Mackay
Chief Financial Officer
TW
Tony Wood
Chief Scientific Officer
DW
Deborah Waterhouse
Chief Executive Officer, Vaccines
LM
Luke Miels
Chief Commercial Officer
KT
Karenann Terrell
Chief Digital and Technology Officer
DC
Diana Conrad
Chief Legal Officer
RC
Roger Connor
President, Global Affairs
View full GSK plc profile